Chroma Therapeutics

Chroma Therapeutics is a privately held biotechnology company focused on the discovery and development of novel small molecule drugs based on chromatin biology and innovative cell accumulation methods. Chroma is the first company to systematically consolidate intellectual property related to chromatin biology and has established a robust network of academic collaborators. Chroma aims to build significant shareholder value by creating a broad and innovative pipeline of products designed to treat highly prevalent cancers and inflammatory diseases.